Health
Chemical biomarker could be used to better manage treatments for COVID-19 – News-Medical.Net
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…

Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesised in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.
…
-
Business18 hours ago
Warning! These ASX 200 shares were just downgraded
-
Business11 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
General7 hours ago
Calls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
Noosa News11 hours ago
Vegetables and herbs you can easily and cheaply grow from seeds